You just read:

Aptinyx Granted Fast Track Designation, Initiates Phase 1 for Second Clinical Candidate, NYX-783, in Post-Traumatic Stress Disorder

News provided by

Aptinyx Inc.

Dec 07, 2017, 07:00 EST